Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The document concludes that more inclusive research involving the transgender community is needed, especially on the neovaginal microbiome of trans women.

The critique suggests that Wilton's work unintentionally supports the very stereotypes it aims to question and calls for a broader, more inclusive approach to understanding gender.

Improved access to hair removal is crucial for transgender individuals before feminizing surgeries.

Hormone therapy with estradiol and spironolactone can regrow scalp hair in transgender women by lowering testosterone to female levels.

Inclusive and culturally competent healthcare is crucial for transgender and non-binary individuals.

The document concludes that individualized Facial Feminization Surgery plans and comprehensive care are crucial for successful outcomes.

Dihydrotestosterone has a reduced effect on muscle-building in people with testicular feminization syndrome, especially after their gonads are removed.

Testosterone therapy in transgender men can cause acne.

Most transgender adolescents continued hormone treatment, with few stopping due to reasons other than returning to their birth gender.

Masculinizing hormone therapy increases the risk of hair loss in transgender and gender-diverse patients.

Long-pulsed ruby laser effectively reduces hair in male-to-female transsexuals.

Transgender patients face more barriers to oral healthcare, leading to poorer oral health and quality of life.

Psoriasis rates in transgender people are similar to the general population, but hormone therapy might affect it.

Testosterone increases hair growth and acne in transgender men.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

The transgender community in India has specific skin care needs and struggles to access dermatological services due to discrimination and financial issues.

Testosterone treatment in transgender teens can worsen acne, requiring careful treatment due to mental health and medication side effects.

Research on transgender men needs clearer theories to improve understanding and decision-making.

Bilateral Orchiectomy effectively reduces the need for anti-androgen medication in most transgender females.

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.

Cyproterone acetate is a safe treatment that causes mild feminizing effects in adolescent trans-girls.

Individuals with this condition often develop male traits and identities at puberty despite being raised as females.

Oocyte retrieval is possible for transgender men on testosterone therapy without affecting fertility outcomes.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

The best treatment varies per individual, but options include minoxidil, finasteride, PRP, and LLLT.

Testosterone undecanoate increases lean mass and causes various physical changes in female-to-male transsexuals.